MAPT and Alzheimer disease: Indeed, reports confirm that Aβ and Tau activities in human brain homogenates from Alzheimer’s patients [2, 3] and microglia and astrocytes are moderators of Aβ clearance and degradation that play critical roles in AD pathology.